Scott Henry
Stock Analyst at Alliance Global Partners
(1.69)
# 3,180
Out of 4,761 analysts
60
Total ratings
40.38%
Success rate
-3.46%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $1.71 | +119.30% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $3.12 | +92.31% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $3.38 | +195.86% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $2.75 | $0.81 | +238.34% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $5.19 | +63.78% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $1.03 | +288.35% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $1.62 | +825.93% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $12 | $1.57 | +664.33% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $10.17 | -26.25% | 2 | Sep 22, 2023 | |
| DCTH Delcath Systems | Maintains: Buy | $10 → $13 | $14.88 | -12.63% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $34.07 | -29.56% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $120.67 | -25.42% | 9 | Dec 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $21.62 | -28.31% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $99.54 | -41.73% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $56.24 | -35.99% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.51 | +630.90% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $5.38 | +11.52% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $3.12 | +184,194.87% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.36 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $5.71 | +22.59% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $9.17 | - | 5 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.63 | - | 2 | Mar 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.67 | - | 1 | Nov 10, 2017 |
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $1.71
Upside: +119.30%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $3.12
Upside: +92.31%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $3.38
Upside: +195.86%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $2.75
Current: $0.81
Upside: +238.34%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $5.19
Upside: +63.78%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $1.03
Upside: +288.35%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $1.62
Upside: +825.93%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $12
Current: $1.57
Upside: +664.33%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $10.17
Upside: -26.25%
Delcath Systems
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $14.88
Upside: -12.63%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $34.07
Upside: -29.56%
Dec 23, 2022
Maintains: Buy
Price Target: $85 → $90
Current: $120.67
Upside: -25.42%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $21.62
Upside: -28.31%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $99.54
Upside: -41.73%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $56.24
Upside: -35.99%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $1.51
Upside: +630.90%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $5.38
Upside: +11.52%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $3.12
Upside: +184,194.87%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $5.36
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $5.71
Upside: +22.59%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $9.17
Upside: -
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $0.63
Upside: -
Nov 10, 2017
Downgrades: Neutral
Price Target: n/a
Current: $3.67
Upside: -